-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Biocryst Pharmaceuticals Inc quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q1 2024.
- Biocryst Pharmaceuticals Inc Operating Lease, Payments for the quarter ending March 31, 2024 was $525K, a 24.1% increase year-over-year.
- Biocryst Pharmaceuticals Inc Operating Lease, Payments for the twelve months ending March 31, 2024 was $2.02M, a 44% increase year-over-year.
- Biocryst Pharmaceuticals Inc annual Operating Lease, Payments for 2023 was $1.92M, a 23.5% increase from 2022.
- Biocryst Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $1.56M, a 4.36% increase from 2021.
- Biocryst Pharmaceuticals Inc annual Operating Lease, Payments for 2021 was $1.49M, a 12.1% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)